ArticleTherapeutic advances in medical oncology2020

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:

Jakob Michael Riedl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.